Dr Lal Pathlabs informs about impact of covid 19 pandemic

02 Jun 2020 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. SEBI/HO/CFD/CMD1/CIR/P/2020/84 dated May 20, 2020, Dr Lal Pathlabs has informed that it has submitted the disclosure of material impact of COVID-19 pandemic on the business and operations of the Company.

The above information is a part of company’s filings submitted to BSE.


Dr. Lal Pathlabs Share Price

2299.00 30.10 (1.33%)
28-Mar-2024 16:01 View Price Chart
Peers
Company Name CMP
Aster DM Healthcare 407.30
Apollo Hospital Ent. 6347.35
Max Healthcare Inst 820.40
Narayana Hrudayalay 1293.60
Global Health 1323.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.